Collins James J. is a director of Orion Biotech Opportunities Corp.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Senti Biosciences, Inc.
12 Jul 24
4
Fulcrum Therapeutics, Inc.
18 Jun 24
4
Fulcrum Therapeutics, Inc.
29 Jun 23
4
Senti Biosciences, Inc.
21 Jun 23
4
Orion Biotech Opportunities Corp.
18 May 23
4
Senti Biosciences, Inc.
15 Jul 22
4
Fulcrum Therapeutics, Inc.
29 Jun 22
3
Senti Biosciences, Inc.\
15 Jun 22
4
Fulcrum Therapeutics, Inc.
11 Jun 21
3
Orion Biotech Opportunities Corp.
12 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Jul 24 | SNTI Senti Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 62,500 | 19.38 k | 62,500 |
17 Jun 24 | FULC Fulcrum Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7 | 30,000 | 210.00 k | 30,000 |
27 Jun 23 | FULC Fulcrum Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.16 | 30,000 | 94.80 k | 30,000 |
16 Jun 23 | SNTI Senti Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 0.99 | 62,500 | 61.88 k | 62,500 |
17 May 23 | ORIAW Orion Biotech Opportunities | Class B ordinary shares Class A ordinary shares | Sale back to company | Dispose D | No | No | 0 | 40,000 | 0.00 | 0 |